Back
Corporate News
Vivo Bio Tech’s board re-appointed directors for five-year terms, pending shareholder approval
22-Aug-2026, 08:47
Vivo Bio Tech Limited informed the BSE on August 22, 2026, that its board approved the re-appointment of Mr. Sri Kalyan Kompella and Dr. Sankaranarayanan Alangudi as Whole-Time Directors for five-year terms, effective November 03, 2026, and January 06, 2027, respectively, pending shareholder approval, and re-appointed Mr. Kalyan Ram Mangipudi, Whole-Time Director, who retires by rotation. The company will hold its 39th Annual General Meeting on September 30, 2026, via video conferencing.
Vivo Bio Tech Limited informed the BSE on August 22, 2026, that its board approved the re-appointment of Mr. Sri Kalyan Kompella and Dr. Sankaranarayanan Alangudi as Whole-Time Directors for five-year terms, effective November 03, 2026, and January 06, 2027, respectively, pending shareholder approval, and re-appointed Mr. Kalyan Ram Mangipudi, Whole-Time Director, who retires by rotation. The company will hold its 39th Annual General Meeting on September 30, 2026, via video conferencing.